TRXC - TransEnterix, Inc.

NYSE American - NYSE American Delayed Price. Currency in USD
4.71
-0.07 (-1.46%)
At close: 4:00PM EDT

4.64 -0.07 (-1.49%)
After hours: 6:11PM EDT

Stock chart is not supported by your current browser
Previous Close4.78
Open4.85
Bid0.00 x 900
Ask0.00 x 2200
Day's Range4.52 - 4.86
52 Week Range1.27 - 6.98
Volume4,073,524
Avg. Volume6,452,615
Market Cap986.957M
Beta (3Y Monthly)2.00
PE Ratio (TTM)N/A
EPS (TTM)-0.80
Earnings DateNov 7, 2017 - Nov 13, 2017
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est6.17
Trade prices are not sourced from all markets
  • One trader's big call on Target
    CNBC Videos2 months ago

    One trader's big call on Target

    Steve Weiss: investors need to hit this target.

  • Simply Wall St.16 hours ago

    Who Are The Top Investors In TransEnterix Inc (NYSEMKT:TRXC)?

    Every investor in TransEnterix Inc (NYSEMKT:TRXC) should be aware of the most powerful shareholder groups. Insiders often own a large chunk of younger, smaller, companies while huge companies tend to Read More...

  • Here's Why TransEnterix Is Soaring Today
    Motley Fool4 days ago

    Here's Why TransEnterix Is Soaring Today

    Shares jumped after the company notched an important regulatory win. Here's what investors need to know.

  • Business Wire5 days ago

    TransEnterix Receives FDA 510(k) Clearance for 3mm Diameter Instruments

    TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that the Company received FDA 510(k) clearance for 3 millimeter diameter instruments, as well as additional 5 millimeter Senhance System instruments.

  • From Iqvia's Bousbib to Red Hat's Whitehurst: Who made the most from inside stock sales in 3Q2018
    American City Business Journals10 days ago

    From Iqvia's Bousbib to Red Hat's Whitehurst: Who made the most from inside stock sales in 3Q2018

    From Iqvia to Red Hat to Bandwidth, insiders at Triangle companies continued to rake in millions in the third quarter by selling shares, U.S. Securities and Exchange Commission filings show.

  • Benzinga14 days ago

    The Daily Biotech Pulse: TransEnterix's Positive Pre-Announcement, Merit Medical Opens Wallet, GW Pharma To Offer ADS Shares

    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Biotech stocks hitting 52-week highs on Oct. 1) Abbott Laboratories (NYSE: ABT ) AstraZeneca plc (NYSE: ...

  • Business Wire14 days ago

    TransEnterix Provides Corporate Update

    TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between surgeons and patients to improve minimally invasive surgery, today provided a corporate update, including preliminary unaudited revenue for the third quarter ended September 30, 2018. “We made significant progress during the third quarter, including the continued adoption of Senhance, driven by the advancement of our sales and marketing strategy, the announcement of the MST acquisition agreement and the expansion of our instrument portfolio," said Todd M. Pope, President and CEO at TransEnterix. For the third quarter ended September 30, 2018, the Company expects to report revenue of approximately $5.4 million.

  • Business Wire15 days ago

    TransEnterix Receives CE Mark Approval for Senhance Ultrasonic Instrument System

    TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that the Company received CE Mark approval for its Senhance Ultrasonic Instrument System.

  • Why TNDM’s Stock Price Rose 7.4% on September 25
    Market Realist20 days ago

    Why TNDM’s Stock Price Rose 7.4% on September 25

    On September 25, Tandem Diabetes Care’s (TNDM) stock price closed at $47.84, which represents ~7.43% growth from the close of $44.53 on September 24. On September 20, Tandem Diabetes Care’s stock price grew 8.09% to 43.18 from the close of $39.95 on September 19.

  • TransEnterix's MST Medical Buyout to Boost Senhance Platform
    Zacks22 days ago

    TransEnterix's MST Medical Buyout to Boost Senhance Platform

    TransEnterix (TRXC) acquires Israel-based MST Medical, which will boost surgeons' effectiveness and make procedures quick and error-free.

  • ACCESSWIRE22 days ago

    Today's Research Reports on Trending Tickers: TransEnterix and Neovasc

    NEW YORK, NY / ACCESSWIRE / September 24, 2018 / U.S. markets were mixed on Friday, with the Dow Jones managing to close at an all-time high despite a plunge in technology and internet stocks. The Dow Jones Industrial Average gained 0.32 percent to close at 26,743.50, while the S&P 500 Index declined 0.04 percent to close at 2,929.67.

  • Business Wire22 days ago

    TransEnterix Acquires Assets, Intellectual Property and Retains R&D Team from MST Medical Surgery Technologies

    TransEnterix, Inc. (NYSE American: TRXC), a medical device company that is digitizing the interface between surgeons and patients to improve minimally invasive surgery, today announced that it has acquired substantially all of the assets of MST Medical Surgery Technologies Ltd. (“MST”), an Israel medical technology company, in a cash and stock transaction with a total consideration, further described below. MST is a leader in the field of surgical technology, having developed a software-based image analytics platform powered by advanced visualization, scene recognition, artificial intelligence, machine learning and data analytics.

  • How Financially Strong Is TransEnterix Inc (NYSEMKT:TRXC)?
    Simply Wall St.24 days ago

    How Financially Strong Is TransEnterix Inc (NYSEMKT:TRXC)?

    Investors are always looking for growth in small-cap stocks like TransEnterix Inc (NYSEMKT:TRXC), with a market cap of US$1.36b. However, an important fact which most ignore is: how financially healthyRead More...

  • Business Wire25 days ago

    TransEnterix to Participate in Two Upcoming Healthcare Conferences

    TransEnterix, Inc. announced today that TransEnterix will participate in two upcoming healthcare conferences:

  • CNBClast month

    Cramer's lightning round: I'm not the call on how to play Roku

    Jim Cramer rattles off his take on callers' favorite stocks, including a streaming play that he's gotten wrong in the past.

  • Motley Foollast month

    How Intuitive Surgical, Inc. Shares Went Up 10% Last Month

    The robotic surgery specialist posted another big month on nothing more substantial than a single, tight-lipped analyst action.

  • Business Wirelast month

    TransEnterix Announces FDA 510(k) Submission for Senhance Ultrasonic Instrument System

    TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between surgeons and patients to improve minimally invasive surgery, today announced the Company filed a FDA 510(k) submission for its Senhance Ultrasonic Instrument System. Advanced energy devices, including ultrasonic devices, represent some of the most versatile and critical tools for surgeons in minimally invasive surgery. “Advanced energy devices are an important tool within laparoscopic surgery because of their applicability within a wide range of procedures,” said Todd M. Pope, TransEnterix CEO.

  • Business Wirelast month

    TransEnterix, Inc. Appoints Eric Smith as Chief Commercial Officer

    TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that Eric Smith has been named Chief Commercial Officer, effective August 31, 2018. In this newly created role, which will report directly to the Chief Executive Officer, Mr. Smith will lead the company’s global commercialization efforts, with a focus on both strategic and tactical execution efforts in sales, upstream and downstream marketing, field clinical support and training with a focus on adoption and clinical excellence. “We are very excited to have Eric join the TransEnterix team.

  • TransEnterix Stock Saw 18% Growth in Week Ended August 24
    Market Realist2 months ago

    TransEnterix Stock Saw 18% Growth in Week Ended August 24

    On August 24, TransEnterix (TRXC) stock closed at $5.37, which represents a ~6.13% growth from its prior day’s close of $5.06. On August 24, TransEnterix closed at $5.37, which is ~12% below its 52-week high of $6.04 on June 27. TransEnterix, a medical device company, is focused on the development of minimally invasive surgical devices with the digitalization of the interface between the surgeon and the patient.

  • TransEnterix Expected to Report Solid Rise in Revenues in 2018
    Market Realist2 months ago

    TransEnterix Expected to Report Solid Rise in Revenues in 2018

    TransEnterix (TRXC) expects to sell three Senhance systems in Q3 2018. While the company expects lower capital sales in the third quarter, it expects sales to be stronger in Q4 2018. Wall Street analysts have projected TransEnterix’s fiscal 2018 revenues to be around $24.7 million, which would be a YoY rise of approximately 248%.

  • What Analysts Recommend for TransEnterix and Peers in August 2018
    Market Realist2 months ago

    What Analysts Recommend for TransEnterix and Peers in August 2018

    In Q2 2018, TransEnterix (TRXC) sold four Senhance surgical robots. Senhance is approved in the US for multiple digital laparoscopic procedures such as an inguinal hernia, colorectal surgery, cholecystectomy surgery, and gynecologic surgery. TransEnterix aims to expand the penetration of surgical robotics globally, which currently stands under 10%.

  • Business Wire2 months ago

    TransEnterix to Present at the 13th Annual Wells Fargo Securities Healthcare Conference

    TransEnterix, Inc. announced today that Todd M. Pope, President and Chief Executive Officer, and Joseph P. Slattery, Executive Vice President and Chief Financial Officer, will present at the 13th Annual Wells Fargo Securities Healthcare Conference at The Westin Copley Place in Boston, Massachusetts.

  • Thomson Reuters StreetEvents2 months ago

    Edited Transcript of TRXC earnings conference call or presentation 7-Aug-18 12:30pm GMT

    Q2 2018 Transenterix Inc Earnings Call

  • Why TransEnterix Stock Rocketed Higher in July
    Motley Fool2 months ago

    Why TransEnterix Stock Rocketed Higher in July

    Shares of this tiny robotic-surgery company benefited from a positive corporate update last month.